Mark Bunker

1.8k citations

32 papers · 1.2k indexed · h-index 15

Impact in

Neurology top 1%
- Vagus Nerve Stimulation Research
- Neurological disorders and treatments
Psychiatry and Mental health top 2%
- Epilepsy research and treatment
- Electroconvulsive Therapy Studies

Papers in ⓘ

Neurology 20
- Vagus Nerve Stimulation Research 20
- Neurological disorders and treatments 10
Psychiatry and Mental health 13
- Epilepsy research and treatment 6
- Electroconvulsive Therapy Studies 5

Co-authors: Charles R. Conway (12 shared papers)Scott T. Aaronson (8 shared papers)Bryan Olin (7 shared papers)Frederick W. Reimherr (2 shared papers)Thomas L. Schwartz (2 shared papers)Darin D. Dougherty (1 shared paper)John Zajecka (2 shared papers)Francisco Moreno (2 shared papers)
Journals: Brain stimulation (3 papers)Biological Psychiatry (2 papers)Journal of Psychiatric Research (2 papers)Epilepsia (2 papers)Epilepsy & Behavior (2 papers)
Partner nations: United States Singapore United Kingdom

In The Last Decade

Mark Bunker

27 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mark Bunker

Since Specialization

Citations

This map shows the geographic impact of Mark Bunker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bunker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bunker more than expected).

Fields of papers citing papers by Mark Bunker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bunker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bunker. The network helps show where Mark Bunker may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Bunker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Bunker Line = papers co-authored together Mark Bunker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality American Journal of Psychiatry ·Scott T. Aaronson, Peter Sears, Francis Ruvuna, Mark Bunker, Charles R. Conway, Darin D. Dougherty, Frederick W. Reimherr, Thomas L. Schwartz, John Zajecka	2017	234
2	Vagus nerve stimulation for drug‐resistant epilepsy: A European long‐term study up to 24 months in 347 children Epilepsia ·Iren Orosz, David McCormick, Nelia Zamponi, Sophia Varadkar, Martha Feucht, D. Parain, Roger Griens, Louis Vallée, Paul Boon, Christopher Rittey, Amara K. Jayewardene, Mark Bunker, Alexis Arzimanoglou, Lieven Lagae	2014	192
3	Vagus Nerve Stimulation Therapy Randomized to Different Amounts of Electrical Charge for Treatment-Resistant Depression: Acute and Chronic Effects Brain stimulation ·Scott T. Aaronson, Linda L. Carpenter, Charles R. Conway, Frederick W. Reimherr, Sarah H. Lisanby, Thomas L. Schwartz, Francisco Moreno, David L. Dünner, Michael D. Lesem, Paul M. Thompson, Mustafa M. Husain, Craig J. Vine, Michael Banov, Lawrence P. Bernstein, Robert B. Lehman, Guy E. Brannon, George A. Keepers, John P. O’Reardon, Richard L. Rudolph, Mark Bunker	2012	126
4	Long‐term surveillance of SUDEP in drug‐resistant epilepsy patients treated with VNS therapy Epilepsia ·Philippe Ryvlin, Elson L. So, Charles M. Gordon, Dale C. Hesdorffer, Michael R. Sperling, Orrin Devinsky, Mark Bunker, Bryan Olin, Daniel Friedman	2018	104
5	Outcome of vagus nerve stimulation for drug‐resistant epilepsy: the first three years of a prospective Japanese registry Epileptic Disorders ·Kensuke Kawai, Tatsuya Tanaka, Hiroshi Baba, Mark Bunker, Akio Ikeda, Yushi Inoue, Shigeki Kameyama, Sunao Kaneko, Amami Kato, Taneyoshi Nozawa, Eiji Maruoka, Makiko Ōsawa, Taisuke Otsuki, Sadatoshi Tsuji, Eiju Watanabe, Takamichi Yamamoto	2017	79
6	The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF) Journal of Psychiatric Research ·Harold A. Sackeïm, Scott T. Aaronson, Mark Bunker, Charles R. Conway, Mark A. Demitrack, Mark S. George, Joan Prudic, Michael E. Thase, A. John Rush	2019	69
7	Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy European Journal of Paediatric Neurology ·Sandra L. Helmers, Mei Sheng Duh, Annie Guérin, Sujata P. Sarda, Thomas M. Samuelson, Mark Bunker, Bryan Olin, Stanley D. Jackson, Edward Faught	2012	66
8	Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression The Journal of Clinical Psychiatry ·Charles R. Conway, Arun Kumar, Willa Xiong, Mark Bunker, Scott T. Aaronson, A. John Rush	2018	62
9	Mortality and Suicide Risk in Treatment-Resistant Depression: An Observational Study of the Long-Term Impact of Intervention PLoS ONE ·Bryan Olin, Amara K. Jayewardene, Mark Bunker, Francisco Moreno	2012	51
10	Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy Epilepsy & Behavior ·Sandra L. Helmers, Mei Sheng Duh, Annie Guérin, Sujata P. Sarda, Thomas M. Samuelson, Mark Bunker, Bryan Olin, Stanley D. Jackson, Edward Faught	2011	46
11	<p>Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression</p> Neuropsychiatric Disease and Treatment ·Arun Kumar, Mark Bunker, Scott T. Aaronson, Charles R. Conway, Anthony J. Rothschild, Giacomo Mordenti, A. John Rush	2019	28
12	Anticholinergic Drug Abuse and Misuse CNS Drugs ·Patricia A. Marken, Steven C. Stoner, Mark Bunker	1996	27
13	The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registry International Journal of Bipolar Disorders ·R. Hamish McAllister‐Williams, Soraia Sousa, Arun Kumar, Teresa Greco, Mark Bunker, Scott T. Aaronson, Charles R. Conway, A. John Rush	2020	21
14	Attenuation of Antipsychotic-Induced Hyperprolactinemia with Clozapine Journal of Child and Adolescent Psychopharmacology ·Mark Bunker, Patricia A. Marken, Mark E. Schneiderhan, Valerie Ruehter	1997	21
15	A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment Contemporary Clinical Trials ·Charles R. Conway, Bryan Olin, Scott T. Aaronson, Harold A. Sackeïm, Mark Bunker, Christopher Kriedt, T. Greco, Kristine Broglio, Matteo Vestrucci, A. John Rush	2020	17
16	Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England Epilepsy & Behavior ·Charlotte Camp, W. Henry Smithson, Mark Bunker, Tom Burke, David Hughes	2015	13
17	<p>The Long and Winding Road of Vagus Nerve Stimulation: Challenges in Developing an Intervention for Difficult-to-Treat Mood Disorders</p> Neuropsychiatric Disease and Treatment ·Harold A. Sackeïm, Maxine Dibué, Mark Bunker, A. John Rush	2020	9
18	Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects Australian & New Zealand Journal of Psychiatry ·Scott T. Aaronson, Harold A. Sackeïm, Mei Jiang, Sarah Badejo, Teresa Greco, Mark Bunker, Charles R. Conway, Koen Demyttenaere, Allan H. Young, R. Hamish McAllister‐Williams, A. John Rush	2023	5
19	A study of the impact of VNS on health care utilisation in England Seizure ·Tom Burke, David Hughes, John Forsey, Mark Bunker, Dev Bhattacharya, W. Henry Smithson	2015	5
20	Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life Psychological Medicine ·Harold A. Sackeïm, A. John Rush, Teresa Greco, Mei Jiang, Sarah Badejo, Mark Bunker, Scott T. Aaronson, Charles R. Conway, Koen Demyttenaere, Allan H. Young, R. Hamish McAllister‐Williams	2023	4

About Mark Bunker

Mark Bunker is a scholar working on Neurology, Psychiatry and Mental health, Neurology, Pharmacology and Cognitive Neuroscience, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Vagus Nerve Stimulation Research (20 papers), Treatment of Major Depression (10 papers), Neurological disorders and treatments (10 papers), Epilepsy research and treatment (6 papers), EEG and Brain-Computer Interfaces (5 papers), Electroconvulsive Therapy Studies (5 papers), Mental Health Research Topics (3 papers) and Heart Rate Variability and Autonomic Control (3 papers). The work is most often cited by research in Neurology (765 citations), Psychiatry and Mental health (479 citations), Biological Psychiatry (71 citations), Neurology (429 citations) and Cognitive Neuroscience (383 citations). Mark Bunker has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include Charles R. Conway, Scott T. Aaronson, Bryan Olin, Frederick W. Reimherr, Thomas L. Schwartz, Darin D. Dougherty, John Zajecka, Francisco Moreno, A. John Rush and Arun Kumar. Their work appears in journals such as Brain stimulation, Biological Psychiatry, Journal of Psychiatric Research, Epilepsia and Epilepsy & Behavior.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact